Clever, Personable, and Unconventional: Plus Therapeutics Presents Data at ESMO Congress 2022

Celebrating Innovative Cancer Treatments with Plus Therapeutics Introduction AUSTIN, Texas, Aug. 23, 2022 (GLOBE NEWSWIRE) – Plus Therapeutics, Inc. (Nasdaq: PSTV) is making waves in the medical world with its cutting-edge approach to cancer treatment. The company focuses on developing targeted radiotherapeutics for rare and difficult-to-treat cancers, offering hope to patients who may have few…

Read More

McAdam Makes the Cut: Named to Inc. 5000 List of Fastest-Growing Private Companies for the 4th Time in 2022!

McAdam Featured On The Inc. 5000 2022 List Of The “Fastest Growing Private Companies in the US” For the 4th Time PHILADELPHIA, Aug. 23, 2022 (GLOBE NEWSWIRE) McAdam, a Philadelphia headquartered financial services firm, was recognized recently in the annual “Inc. 5000” list of fastest growing private companies in America. This is the fourth year…

Read More

GBTS Receives Notice of Publication for Facial and Body Recognition Patent Application: A Breakthrough in Technology!

GBT’s Facial and Body Recognition Patent Application Received a Notice of Publication Introduction Have you ever watched a sci-fi movie and wondered if the technology shown is actually possible in real life? Well, advances in machine learning driven image identification and recognition systems are making futuristic tech a reality. GBT Technologies Inc. recently received a…

Read More

Unlimint Takes Banking to the Next Level with Exciting New BaaS Solution!

Unlimint Launches Unlimint Banking and Cards Product Introduction London-based Unlimint, previously known as Cardpay, announced on Tuesday the launch of Unlimint Banking and Cards (UBC), which is the fintech’s banking-as-a-service (BaaS) product. What is Unlimint Banking and Cards (UBC)? The new product is offering payment accounts along with card issuing and processing solutions to businesses…

Read More

Introducing the Algorithmic Bookbuilder: A Game-Changing Tool for Buy-Side Investors in the Forex Industry

Dr. Robert Barnes: The Man Behind the Innovation Introducing Appital Turquoise BookBuilder™ The Future of Buy-Side Investing Dr. Robert Barnes, Group Head of Securities Trading & CEO Turquoise Global Holdings at London Stock Exchange Group, has made waves in the financial world with the introduction of Appital Turquoise BookBuilder™. This groundbreaking innovation revolutionizes the way…

Read More